AIF1 and neuropathy: In our pilot experiments we consistently saw a decrease in the area and/or number of IBA1-positive cells in DRGs of animals with experimental neuropathies treated with ARTN or RET agonists compared to the values seen in DRGs of animals treated with vehicle (Figure 2).